Clinical Trials in Ohio

Showing 13041-13060 of 20,938 trials

Answer ALS: Individualized Initiative for ALS Discovery

NCT02574390

Creation of a large repository of induced pluripotent stem cells (iPSC), bio-fluid samples (blood and spinal fluid (optional)), and cell lines for ALS gene identification. This will be combined carefully with collected measures of the pattern of the symptoms people with ALS have and how these change over time. People with other motor neuron diseases and healthy controls will be included as comparisons

Amyotrophic Lateral SclerosisPrimary Lateral SclerosisFlail Arm ALS+5 more

Johns Hopkins University1,049 participantsStarted Dec 2015

Los Angeles, California, United States • Atlanta, Georgia, United States • Chicago, Illinois, United States +5 more locations

COMPLETEDPhase 332 miles

Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee

NCT02528188

The purpose of this study is to compare the long-term joint safety and efficacy (pain relief) of the investigational study drug, tanezumab compared to non-steroidal anti inflammatory drugs (NSAIDs) in subjects with osteoarthritis of the hips or knees.

Chronic PainOsteoarthritis, HipOsteoarthritis, Knee

Pfizer3,021 participantsStarted Jul 2015

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Birmingham, Alabama, United States +504 more locations

Answer ALS: Individualized Initiative for ALS Discovery

Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee

Find Trials by Condition in Ohio

Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer

Evaluating the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures

Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry

Global Study Comparing a rivAroxaban-based Antithrombotic Strategy to an antipLatelet-based Strategy After Transcatheter aortIc vaLve rEplacement to Optimize Clinical Outcomes

Safety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in T-cell Lymphoma

Phase III Trial BI 695502 Plus Chemotherapy vs. Avastin® Plus Chemotherapy in Patients With Lung Cancer

Host Genetic Factors Influencing HIV1 and HCV Viral Loads and AIDS Clinical Progression in a Hemophilia Cohort (HGDS-3)

The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis

Safety and Tolerability of TAR-302-5018 in Subjects With Idiopathic Overactive Bladder

Study to Evaluate DNL201 in Subjects With Parkinson's Disease

A 4-Week Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive Sleepiness

Safety and Tolerability of TAR-302-5018 in Subjects With Neurogenic Detrusor Overactivity Resulting From Spinal Cord Injury

An Expanded Access Treatment Protocol of Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Urothelial Carcinoma

Safety of PDT-Photofrin® Prior to Lung Surgery

A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure

COmedication Study Assessing Mono- and cOmbination Therapy With Levodopa-carbidopa inteStinal Gel

Study of Pralatrexate in Female Patients With Previously-treated Breast Cancer

Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid Leukemia